Université de Strasbourg (UNISTRA), Faculté de Médecine, Hôpitaux Universitaires de Strasbourg, Service de Médecine Intensive-Réanimation, Nouvel Hôpital Civil, 1, place de l'Hôpital, 67091, Strasbourg Cedex, France.
INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), FMTS, Strasbourg, France.
Intensive Care Med. 2023 Mar;49(3):273-290. doi: 10.1007/s00134-023-06980-6. Epub 2023 Feb 17.
Coagulopathy is a severe and frequent complication in critically ill patients, for which the pathogenesis and presentation may be variable depending on the underlying disease. Based on the dominant clinical phenotype, the current review differentiates between hemorrhagic coagulopathies, characterized by a hypocoagulable and hyperfibrinolysis state, and thrombotic coagulopathies with a systemic prothrombotic and antifibrinolytic phenotype. We discuss the differences in pathogenesis and treatment of the common coagulopathies.
凝血功能障碍是危重症患者中一种严重且常见的并发症,其发病机制和表现可能因基础疾病而异。基于主要的临床表型,本综述将其分为出血性凝血功能障碍和血栓性凝血功能障碍,前者以低凝和高纤溶状态为特征,后者以全身性促血栓形成和抗纤维蛋白溶解表型为特征。我们讨论了常见凝血功能障碍的发病机制和治疗差异。